These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36473591)

  • 1. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.
    Barrera-Conde M; Veza-Estévez E; Gomis-Gonzalez M; Garcia-Quintana J; Trabsa A; Martínez-Sadurní L; Pujades M; Perez V; de la Torre R; Bergé D; Robledo P
    Neurobiol Dis; 2023 Jan; 176():105942. PubMed ID: 36473591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.
    Spano MS; Fattore L; Cadeddu F; Fratta W; Fadda P
    Psychopharmacology (Berl); 2013 Feb; 225(3):531-42. PubMed ID: 22903392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
    Nabeshima T; Mouri A; Murai R; Noda Y
    Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.
    Gigg J; McEwan F; Smausz R; Neill J; Harte MK
    J Psychopharmacol; 2020 Jan; 34(1):115-124. PubMed ID: 31580184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: a model for schizophrenia.
    Jodo E
    J Physiol Paris; 2013 Dec; 107(6):434-40. PubMed ID: 23792022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
    Ricci V; Ceci F; Di Carlo F; Di Muzio I; Ciavoni L; Santangelo M; Di Salvo G; Pettorruso M; Martinotti G; Maina G
    Psychiatry Res; 2023 Feb; 320():115053. PubMed ID: 36682093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.
    Spano MS; Fadda P; Frau R; Fattore L; Fratta W
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):25-36. PubMed ID: 19854030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
    Morabito MA; Sheng M; Tsai LH
    J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
    Wilkaniec A; Gąssowska-Dobrowolska M; Strawski M; Adamczyk A; Czapski GA
    J Neuroinflammation; 2018 Jan; 15(1):1. PubMed ID: 29301548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.
    Diaz A; Jeanneret V; Merino P; McCann P; Yepes M
    J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30709918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.
    Guinart D; Moreno E; Galindo L; Cuenca-Royo A; Barrera-Conde M; Pérez EJ; Fernández-Avilés C; Correll CU; Canela EI; Casadó V; Cordomi A; Pardo L; de la Torre R; Pérez V; Robledo P
    Schizophr Bull; 2020 Dec; 46(6):1547-1557. PubMed ID: 32249318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclin-dependent kinase-5 in the kainic acid-mediated degeneration of glutamatergic synapses in the rat hippocampus.
    Putkonen N; Kukkonen JP; Mudo G; Putula J; Belluardo N; Lindholm D; Korhonen L
    Eur J Neurosci; 2011 Oct; 34(8):1212-21. PubMed ID: 21978141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.
    Yücel M; Bora E; Lubman DI; Solowij N; Brewer WJ; Cotton SM; Conus P; Takagi MJ; Fornito A; Wood SJ; McGorry PD; Pantelis C
    Schizophr Bull; 2012 Mar; 38(2):316-30. PubMed ID: 20660494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits.
    Liu W; Zhou Y; Liang R; Zhang Y
    FASEB J; 2019 Dec; 33(12):14506-14515. PubMed ID: 31689375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.
    Santini MA; Ratner C; Aznar S; Klein AB; Knudsen GM; Mikkelsen JD
    J Neurosci Res; 2013 May; 91(5):634-41. PubMed ID: 23404493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
    Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
    Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.